HomeMarket ReportsPet Care M&A Surges 22.4% in 2026 as Private Equity Targets Animal...

Pet Care M&A Surges 22.4% in 2026 as Private Equity Targets Animal Health, Wellness and Premium Nutrition

The global pet care industry is attracting renewed merger and acquisition (M&A) interest, with transaction activity increasing 22.4% year-over-year to 60 announced or completed deals in 2026, according to Capstone Partners’ November 2026 Pet Care Market Update.

The report, published last week, identifies private equity investment, strategic acquisitions and growing demand for science-backed pet health and wellness products as important drivers of market activity.

The findings highlight a structural shift in the pet care industry, where investment interest is increasingly moving beyond conventional pet food and accessories towards veterinary healthcare, clinical nutrition, supplements, specialist services and integrated pet care platforms.

1. Private equity emerges as a major growth driver

One of the most important findings is the 56.3% year-over-year increase in private equity-sponsored M&A activity.

Private equity investors are increasingly targeting businesses with differentiated products, specialised intellectual property, attractive margins and opportunities for expansion through acquisitions. Capstone identifies several attractive investment categories:

  • Animal health ingredient suppliers

  • Pet supplement developers

  • Veterinary pharmacy operators

  • Premium branded pet products

  • Specialist veterinary services

  • Boarding, daycare and grooming businesses

  • Integrated veterinary and wellness platforms

The growth of add-on acquisitions is particularly significant. Rather than simply purchasing individual businesses, financial sponsors are increasingly building larger platforms by acquiring complementary businesses and expanding geographical reach, service offerings and customer relationships.

2. Science-backed nutrition is becoming an acquisition priority

A particularly important trend is the growing interest in premium pet consumables with scientifically differentiated formulations. Products containing clinically supported ingredients and formulations designed around measurable health outcomes are increasingly attracting strategic buyers. This includes:

  • Functional nutritional supplements

  • Joint health and mobility products

  • Digestive health formulations

  • Specialised veterinary diets

  • Products supporting healthy ageing

  • Condition-specific nutritional solutions

The commercial rationale is relatively straightforward. Consumers increasingly view pets as family members and are willing to spend on preventive healthcare, nutrition and products that improve quality of life.

The market is consequently moving towards products that offer a more compelling scientific proposition than conventional commodity-based offerings. However, the quality of supporting clinical evidence, regulatory compliance and substantiation of health claims remain important considerations.

3. Strategic buyers return, but public-company activity remains weaker

Capstone’s report identifies a 6.1% increase in strategic acquisition activity. Within this category:

M&A segment
Year-over-year change
Overall pet care transactions
+22.4%
Private equity-sponsored activity
+56.3%
Private strategic acquisitions
+15.4%
Public-company acquisition activity
-28.6%

The figures suggest that private equity and privately held strategic buyers are playing a particularly important role in the current acquisition cycle.

Large strategic players, including Nestlé, Mars and General Mills, are among the companies potentially positioned to pursue differentiated brands and businesses that strengthen their portfolios.

4. Vertical integration is reshaping pet care ecosystems

Another important development is the increasing emphasis on building integrated pet care ecosystems. Companies are attempting to capture a larger share of the pet owner’s lifetime expenditure by combining products, services and healthcare delivery.

One example highlighted in the report is Chewy’s expansion into veterinary healthcare and specialised pet care. Its acquisitions include:

Acquisition
Reported transaction value
Modern Animal, April 2026
$400 million
SmartPak Equine, October 2025
$175 million

These acquisitions illustrate how companies can expand beyond traditional pet retail into veterinary services and specialised animal care. The long-term objective is to establish a more comprehensive relationship with pet owners across nutrition, preventive care, treatment and ongoing health management.

5. What this means for the Indian animal health market

The findings are particularly relevant to India’s developing companion animal healthcare industry. India’s urban pet population, organised veterinary infrastructure and premium pet nutrition segment provide opportunities for businesses operating in:

  1. Veterinary diagnostics and laboratory services

  2. Specialised veterinary hospitals and clinics

  3. Prescription and therapeutic pet nutrition

  4. Pet supplements and functional ingredients

  5. Veterinary pharmacy and distribution

  6. Digital veterinary consultation and healthcare platforms

  7. Preventive healthcare and wellness services

Indian animal health businesses could also become attractive acquisition targets if they establish differentiated capabilities, strong distribution networks, credible brands and sustainable operating economics. For investors, the important distinction will be between businesses benefiting from temporary demand growth and those possessing genuine competitive advantages.

Industry perspective

The 2026 M&A figures suggest that pet care is increasingly being evaluated as a healthcare and wellness investment category rather than simply a consumer-products market.

For animal health companies, this creates opportunities for capital formation, consolidation and expansion. The next wave of value creation may come from businesses that successfully combine clinical credibility, recurring revenue, specialised products and integrated service delivery.

Animal Health India Editorial Team
Animal Health India Editorial Teamhttps://animalhealthindia.com
Animal Health India (AHI) is an independent news and intelligence platform covering the global animal health, veterinary, livestock, poultry, companion animal and pet food sectors. Our editorial team comprises veterinary journalists, animal health professionals, regulatory affairs specialists and industry analysts with over 30 years of combined experience covering India, Asia, Europe and North America. AHI publishes news, regulatory updates, market intelligence and company news drawn from primary sources including DAHD, EMA, USDA, AVMA and leading veterinary publications worldwide.
RELATED ARTICLES